The approval by the U.S. Food and Drug Administration is based on results from the DECLARE-TIMI 58 clinical trial, the London-listed company said, and follows a similar approval by the European authorities in August.from Moneycontrol World News http://bit.ly/2p35AZ5
No comments:
Post a Comment